3-hydroxyflavone has been researched along with Psoriasis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, G; Cao, Z; Liu, Z; Shi, Y; Sun, R; Xu, Q; Yang, N; Zhang, C | 1 |
| Ding, Y; Liu, L; Wang, Y; Wu, Y; Zhao, R | 1 |
| Wang, H; Wang, W | 1 |
| Adhami, VM; Banang-Mbeumi, S; Chamcheu, JC; Esnault, S; Huang, S; Kousoulas, KG; Mukhtar, H; Noll, AL; Roy, T; Singh, SS | 1 |
| Liu, Y; Meng, L; Tan, X; Wei, G; Xu, Q; Zhang, C | 1 |
| Lu, C; Xiao, Z; Yu, J; Zhang, Y; Zhao, R | 1 |
| Di, TT; Li, P; Liu, X; Ruan, ZT; Wang, Y; Zhao, JX | 1 |
7 other study(ies) available for 3-hydroxyflavone and Psoriasis
| Article | Year |
|---|---|
Topical astilbin ameliorates imiquimod-induced psoriasis-like skin lesions in SKH-1 mice via suppression dendritic cell-Th17 inflammation axis.
Topics: Animals; Cytokines; Dendritic Cells; Disease Models, Animal; Flavonols; Imiquimod; Inflammation; Keratinocytes; Mice; Mice, Inbred BALB C; Psoriasis; Skin | 2022 |
Optimization of the Transdermal Delivery System in Astilbin Microemulsion with Improved Stability and Anti-psoriatic Activity.
Topics: Administration, Cutaneous; Animals; Emulsions; Flavonols; Gallic Acid; Mice; Particle Size; Psoriasis; Solubility | 2023 |
Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease.
Topics: Animals; Disease Models, Animal; Flavonols; Interleukin-17; Keratinocytes; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; Psoriasis; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2019 |
Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.
Topics: Cell Survival; Cells, Cultured; Flavonoids; Flavonols; Humans; Inflammation; Keratinocytes; MAP Kinase Signaling System; Models, Biological; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psoriasis; Skin; TOR Serine-Threonine Kinases | 2019 |
Astilbin decreases proliferation and improves differentiation in HaCaT keratinocytes.
Topics: Anti-Inflammatory Agents; Cell Differentiation; Cell Line; Cell Proliferation; China; Cyclin-Dependent Kinase Inhibitor p21; Flavonols; Humans; Inflammation; Keratinocytes; Keratins; Psoriasis; Rhizome; S Phase; Tumor Suppressor Protein p53 | 2017 |
Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK.
Topics: Animals; Anti-Inflammatory Agents; Cell Line, Transformed; Disease Models, Animal; Ear; Emulsions; Flavonols; Gene Expression Regulation; Guinea Pigs; Humans; Immunologic Factors; Interleukin-17; Interleukin-22; Interleukin-6; Interleukins; Keratinocytes; Lipopolysaccharides; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Propranolol; Psoriasis; Signal Transduction | 2018 |
Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Proliferation; Flavonols; Imiquimod; Immunologic Factors; Interleukin-17; Janus Kinase 3; Keratinocytes; Male; Mice, Inbred BALB C; Psoriasis; Signal Transduction; Skin; STAT3 Transcription Factor; Th17 Cells | 2016 |